Armata Pharmaceuticals(ARMP) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Armata Pharmaceuticals Announces First Quarter 2025 Results and Provides Corporate Update LOS ANGELES, CA, May 14, 2025 - Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announced financial results for its first quarter ended March 31, 2025, and p ...